- Comparison of Prospective and Retrospective Indicators of the Quality of End-of-Life Cancer Care
[作者:Setoguchi, S; Earle, CC; Glynn, R; Stedman, M; Polinski, JM; Corcoran, CP; Haas, JS,期刊:Journal of clinical oncology, 页码:5671-5678 , 文章类型: Article,,卷期:2008年26-35]
- PurposeTo compare prospectively and retrospectively defined benchmarks for the quality of end-of-life care, including a novel indicator for the use of opiate analgesia.MethodsLinked claims and cancer registry data from 1...
- Human Epidermal Growth Factor Receptor 2 Overexpression As a Prognostic Factor in a Large Tissue Microarray Series of Node-Negative Breast Cancers
[作者:Chia, S; Norris, B; Speers, C; Cheang, M; Gilks, B; Gown, AM; Huntsman, D; Olivotto, IA; Nielsen, TO; Gelmon, K,期刊:Journal of clinical oncology, 页码:5697-5704 , 文章类型: Article,,卷期:2008年26-35]
- PurposeHuman epidermal growth factor receptor 2 gene (HER2) is associated with a poorer outcome in node-positive breast cancer, but the results are conflicting in node-negative disease. This study assessed the prognostic...
- Randomized Comparison of Cooked and Noncooked Diets in Patients Undergoing Remission Induction Therapy for Acute Myeloid Leukemia
[作者:Gardner, A; Mattiuzzi, G; Faderl, S; Borthakur, G; Garcia-Manero, G; Pierce, S; Brandt, M; Estey, E,期刊:Journal of clinical oncology, 页码:5684-5688 , 文章类型: Article,,卷期:2008年26-35]
- PurposeA neutropenic diet is often used to prevent infection in patients with acute myeloid leukemia (AML). Although such a diet potentially entails inconvenience, its value is uncertain.Patients and MethodsOne hundred f...
- Wild-Type BRAF Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer
[作者:Di Nicolantonio, F; Martini, M; Molinari, F; Sartore-Bianchi, A; Arena, S; Saletti, P; De Dosso, S; Mazzucchelli, L; Frattini, M; Siena, S; Bardelli, A,期刊:Journal of clinical oncology, 页码:5705-5712 , 文章类型: Article,,卷期:2008年26-35]
- PurposeCetuximab or panitumumab are effective in 10% to 20% unselected metastatic colorectal cancer (CRC) patients. KRAS mutations account for approximately 30% to 40% patients who are not responsive. The serine-threonin...
- Cohort Study of Fatty Acid Synthase Expression and Patient Survival in Colon Cancer
[作者:Ogino, S; Nosho, K; Meyerhardt, JA; Kirkner, GJ; Chan, AT; Kawasaki, T; Giovannucci, EL; Loda, M; Fuchs, CS,期刊:Journal of clinical oncology, 页码:5713-5720 , 文章类型: Article,,卷期:2008年26-35]
- PurposeEnergy balance seems to be important in the pathogenesis of colon cancer. Fatty acid synthase (FASN) is physiologically regulated by energy balance and is often upregulated in colorectal cancer. Nonetheless, the i...
- Five-Year Data and Prognostic Factor Analysis of Oxaliplatin and Irinotecan Combinations for Advanced Colorectal Cancer: N9741
[作者:Sanoff, HK; Sargent, DJ; Campbell, ME; Morton, RF; Fuchs, CS; Ramanathan, RK; Williamson, SK; Findlay, BP; Pitot, HC; Goldberg, RM,期刊:Journal of clinical oncology, 页码:5721-5727 , 文章类型: Article,,卷期:2008年26-35]
- PurposeIn this report, we update survival (OS) and time-to-progression (TTP) data for the Intergroup trial N9741 after a median 5 years of follow-up by using risk-stratified and prognostic factor analyses to determine if...
- Risk Factors for Acute Graft-Versus-Host Disease After Human Leukocyte Antigen-Identical Sibling Transplants for Adults With Leukemia
[作者:Hahn, T; McCarthy, PL; Zhang, MJ; Wang, D; Arora, M; Frangoul, H; Gale, RP; Hale, GA; Horan, J; Isola, L; Maziarz, RT; van Rood, JJ; Gupta, V; Halter, J; Reddy, V; Tiberghien, P; Litzow, M; Anasetti, C; Pavletic, S; Ringden, O,期刊:Journal of clinical oncology, 页码:5728-5734 , 文章类型: Article,,卷期:2008年26-35]
- PurposeAcute graft-versus-host disease (GVHD) causes substantial morbidity and mortality after human leukocyte antigen (HLA)-identical sibling transplants. No large registry studies of acute GVHD risk factors have been r...
- Phase III Trial Comparing Concurrent Biochemotherapy With Cisplatin, Vinblastine, Dacarbazine, Interleukin-2, and Interferon Alfa-2b With Cisplatin, Vinblastine, and Dacarbazine Alone in Patients With Metastatic Malignant Melanoma (E3695): A Trial Coordinated by the Eastern Cooperative Oncology Group
[作者:Atkins, MB; Hsu, J; Lee, S; Cohen, GI; Flaherty, LE; Sosman, JA; Sondak, VK; Kirkwood, JM,期刊:Journal of clinical oncology, 页码:5748-5754 , 文章类型: Article,,卷期:2008年26-35]
- PurposePhase II trials with biochemotherapy (BCT) have shown encouraging response rates in metastatic melanoma, and meta-analyses and one phase III trial have suggested a survival benefit. In an effort to determine the r...
- Improved Survival in Lymphoma Patients Receiving Sirolimus for Graft-Versus-Host Disease Prophylaxis After Allogeneic Hematopoietic Stem-Cell Transplantation With Reduced-Intensity Conditioning
[作者:Armand, P; Gannamaneni, S; Kim, HT; Cutler, CS; Ho, VT; Koreth, J; Alyea, EP; LaCasce, AS; Jacobsen, ED; Fisher, DC; Brown, JR; Canellos, GP; Freedman, AS; Soiffer, RJ; Antin, JH,期刊:Journal of clinical oncology, 页码:5767-5774 , 文章类型: Article,,卷期:2008年26-35]
- PurposeInhibitors of the mammalian target of rapamycin (mTOR) kinase have shown clinical activity in several lymphoma subtypes. Sirolimus, an mTOR inhibitor, also has activity in the treatment and prophylaxis of graft-ve...
- Clinical Importance of Estrogen Receptor beta Isoforms in Breast Cancer
[作者:Speirs, V; Green, AR; Hughes, TA; Ellis, IO; Saunders, PTK; Shaaban, AM,期刊:Journal of clinical oncology, 页码:5825-5825 , 文章类型: Letter,,卷期:2008年26-35]
-
|